Genscript Biotech company profile
Company profile
Genscript Biotech has 6,135 employees and is headquartered in Wan Chai, Hong Kong.
Operating with 6,135 employees, Genscript Biotech Corporation works in three areas: life science research products and services, biologics development and industrial synthetic biology. Its research range includes SurePAGE precast gels, CytoSinct cell isolation products, eZwest Lite western blotting devices and GenBox electrophoresis tanks, used in life-science research. The biologics unit helps biopharmaceutical and biotech companies develop therapeutic antibodies and gene and cell therapy products, while the industrial unit makes enzymes through non-pathogenic microbial strains. Its activities serve the United States, Europe, Mainland China and the wider Asia Pacific region.
In the fiscal year ended December 2025, revenue reached USD 959.5 million, up 61.4% from the previous year, while the company posted a net loss of USD 532.8 million. Founded in 2002, the group is headquartered in Wan Chai, Hong Kong.
Company facts
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Hong Kong SAR China
- Headquarters
- Dah Sing Financial Centre, Wan Chai
- Employees
- 6,135
- Chief executive
- Weihui Shao
- Founded
- 2002
- Fiscal year
- January - December
- Listing
- 1548 · HKEX
- Currency
- HKD
- ISIN
- KYG3825B1059
- Website
- genscript.com
Genscript Biotech and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Genscript Biotech1548 | Hong Kong SAR China | $8.77B | 6,135 | 14.9% | — |
| Haisco Pharmaceutical Group002653 | China | $8.97B | 5,597 | 21.1% | 44.1 |
| ALTEOGEN196170 | South Korea | $9.05B | 181 | 47.2% | 97.1 |
| Pharmaron Beijing300759 | China | $10.59B | 25,088 | 14.0% | 39.3 |
| Akeso9926 | Hong Kong SAR China | $6.81B | 4,082 | -30.7% | — |
| Sino Biopharmaceutical1177 | Hong Kong SAR China | $11.65B | 22,838 | 28.2% | 34.2 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
